227 related articles for article (PubMed ID: 29951651)
1. The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Mazza A; Schiavon L; Rigatelli G; Torin G; Montanaro F; Lenti S
Food Funct; 2018 Jul; 9(7):3845-3852. PubMed ID: 29951651
[TBL] [Abstract][Full Text] [Related]
2. Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome.
Mazza A; Lenti S; Schiavon L; Di Giacomo E; Tomasi M; Manunta R; Torin G; Townsend DM; Rubello D
Biomed Pharmacother; 2018 Sep; 105():992-996. PubMed ID: 30021394
[TBL] [Abstract][Full Text] [Related]
3. The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.
Mazza A; Schiavon L; Rigatelli G; Torin G; Lenti S
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):345-350. PubMed ID: 31352663
[TBL] [Abstract][Full Text] [Related]
4. Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
Mazza A; Lenti S; Schiavon L; Zuin M; D'Avino M; Ramazzina E; Casiglia E
Adv Ther; 2015 Jul; 32(7):680-90. PubMed ID: 26202829
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Novel Nutraceutical Formulation Added to Ezetimibe in Statin-Intolerant Hypercholesterolemic Subjects with Moderate-to-High Cardiovascular Risk.
Mazza A; Nicoletti M; Lenti S; Torin G; Rigatelli G; Pellizzato M; Fratter A
J Med Food; 2021 Jan; 24(1):59-66. PubMed ID: 32456525
[TBL] [Abstract][Full Text] [Related]
6. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
7. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
[TBL] [Abstract][Full Text] [Related]
8. Effects of monacolin K-containing nutraceutical on cholesterol homeostasis re-establishment and CVD risk reduction in hypercholesterolemic subjects.
Gojkovic T; Vladimirov S; Kotur-Stevuljevic J; Bogavac-Stanojevic N; Zeljkovic A; Vekic J; Antonic T; Spasojevic-Kalimanovska V
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5261-5267. PubMed ID: 34486702
[TBL] [Abstract][Full Text] [Related]
9. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
Heinz T; Schuchardt JP; Möller K; Hadji P; Hahn A
Nutr Res; 2016 Oct; 36(10):1162-1170. PubMed ID: 27865358
[TBL] [Abstract][Full Text] [Related]
10. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia.
Wang TJ; Lien AS; Chen JL; Lin CH; Yang YS; Yang SH
Am J Chin Med; 2019; 47(2):323-335. PubMed ID: 30871361
[TBL] [Abstract][Full Text] [Related]
12. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
13. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
14. [Red yeast rice, monacolin K, and pleiotropic effects.].
Cicero AFG
Recenti Prog Med; 2018 Feb; 109(2):154e-157e. PubMed ID: 29493648
[TBL] [Abstract][Full Text] [Related]
15. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
[TBL] [Abstract][Full Text] [Related]
16. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia.
Tshongo Muhindo C; Ahn SA; Rousseau MF; Dierckxsens Y; Hermans MP
Complement Ther Med; 2017 Dec; 35():140-144. PubMed ID: 29154060
[TBL] [Abstract][Full Text] [Related]
20. Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials.
Liasi E; Kantilafti M; Hadjimbei E; Chrysostomou S
Semergen; 2024; 50(4):102156. PubMed ID: 38310834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
